Lam Research
LRCX
266.99
-5.22
-1.92%
Lam Research
US · LRCX
#39 by market cap
Listed 1970
266.99
-5.22
-1.92%
Live - 5344 symbols - heartbeat 50s ago
· 2026-10-20 11:00
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 22.84, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +26.02% YoY
Margins
- Gross margin
- 50.47%
- Operating margin
- 35.29%
- Net margin
- 31.27%
Key ratios & quality
- Enterprise valuei
- 332.26B
- PEG ratioi
- 2.69
- Altman Z-Scorei
- 22.84
PEG uses trailing P/E against the 3-year net income growth rate (17.22%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.65B | 10.04B | 14.63B | 17.23B | 17.43B | 14.91B | 18.44B | 23.23B |
| Gross profit | 4.36B | 4.61B | 6.81B | 7.87B | 7.78B | 7.05B | 8.98B | 11.73B |
| Selling & admin expenses | 702.41M | 682.48M | 829.88M | 885.74M | 832.75M | 868.25M | 981.70M | 1.15B |
| Research & development | 1.19B | 1.25B | 1.49B | 1.60B | 1.73B | 1.90B | 2.10B | 2.38B |
| Operating profit | 2.46B | 2.67B | 4.48B | 5.38B | 5.22B | 4.28B | 5.90B | 8.20B |
| Pretax profit | 2.45B | 2.57B | 4.37B | 5.19B | 5.11B | 4.36B | 5.96B | 8.26B |
| Tax | 255.14M | 323.23M | 462.35M | 587.83M | 598.28M | 532.45M | 599.91M | 997.08M |
| Net profit | 2.19B | 2.25B | 3.91B | 4.61B | 4.51B | 3.83B | 5.36B | 7.27B |
| Basic EPS | 1 | 2 | 3 | 3 | 3 | 3 | 4 | 6 |
| Diluted EPS | 1.37 | 1.51 | 2.69 | 3.28 | 3.32 | 2.90 | 4.15 | 5.76 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.72B | 5.17B | 5.32B | 5.34B | 5.84B | 6.72B |
| Gross profit | 2.31B | 2.59B | 2.68B | 2.65B | 2.91B | 3.48B |
| Selling & admin expenses | 226.02M | 268.40M | 279.35M | 267.65M | 280.31M | 322.33M |
| Research & development | 525.90M | 580.18M | 576.45M | 573.31M | 583.20M | 642.92M |
| Operating profit | 1.56B | 1.74B | 1.83B | 1.81B | 2.05B | 2.51B |
| Pretax profit | 1.54B | 1.78B | 1.86B | 1.84B | 2.01B | 2.56B |
| Tax | 206.06M | 58.89M | 290.50M | 242.62M | 186.10M | 277.86M |
| Net profit | 1.33B | 1.72B | 1.57B | 1.59B | 1.83B | 2.28B |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 1.03 | 1.35 | 1.24 | 1.26 | 1.45 | 1.81 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.56B | 10.85B | 11.65B | 12.29B | 13.23B | 12.88B | 14.52B | 15.61B |
| Cash & ST investments | 5.43B | 6.71B | 5.73B | 3.66B | 5.34B | 5.85B | 6.39B | 5.58B |
| Inventory | 1.54B | 1.90B | 2.69B | 3.97B | 4.82B | 4.22B | 4.31B | 4.28B |
| Total assets | 12.00B | 14.56B | 15.89B | 17.20B | 18.78B | 18.74B | 21.35B | 23.53B |
| Total current liabilities | 2.37B | 3.16B | 3.53B | 4.56B | 4.18B | 4.34B | 6.57B | 5.94B |
| Short-term debt | 667.13M | 839.88M | 11.35M | 7.38M | 8.36M | 504.81M | 754.31M | 4.07M |
| Long-term debt | 3.82B | 4.96B | 4.95B | 4.96B | 4.96B | 4.47B | 3.72B | 3.72B |
| Total liabilities | 7,278,029,000.00 | 9,375,558,000.00 | 9,864,964,000.00 | 10,917,266,000.00 | 10,571,471,000.00 | 10,205,274,000.00 | 11,483,641,000.00 | 11,058,822,000.00 |
| Total equity | 4.72B | 5.18B | 6.03B | 6.28B | 8.21B | 8.54B | 9.86B | 12.47B |
| Retained earnings | 9.93B | 11.52B | 14.68B | 18.45B | 22.03B | 24.81B | 28.99B | 34.95B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 13.46B | 14.52B | 14.81B | 14.02B | 13.30B | 15.61B |
| Cash & ST investments | 5.45B | 6.39B | 6.69B | 6.18B | 4.75B | 5.58B |
| Inventory | 4.46B | 4.31B | 4.10B | 4.04B | 4.00B | 4.28B |
| Total assets | 19.97B | 21.35B | 21.90B | 21.39B | 20.79B | 23.53B |
| Total current liabilities | 5.49B | 6.57B | 6.71B | 6.21B | 5.24B | 5.94B |
| Short-term debt | 754.31M | 754.31M | 754.36M | 754.01M | 4.10M | 4.07M |
| Long-term debt | 3.73B | 3.72B | 3.73B | 3.73B | 3.73B | 3.72B |
| Total liabilities | 10,457,205,000.00 | 11,483,641,000.00 | 11,707,459,000.00 | 11,245,745,000.00 | 10,207,131,000.00 | 11,058,822,000.00 |
| Total equity | 9.51B | 9.86B | 10.19B | 10.15B | 10.58B | 12.47B |
| Retained earnings | 27.56B | 28.99B | 30.23B | 31.50B | 33.00B | 34.95B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.18B | 2.13B | 3.59B | 3.10B | 5.18B | 4.65B | 6.17B | 5.86B |
| Depreciation & amortization | 309.28M | 268.53M | 307.15M | 333.74M | 342.43M | 359.70M | 386.28M | 441.53M |
| Free cash flow | 2.87B | 1.92B | 3.24B | 2.55B | 4.68B | 4.26B | 5.41B | 4.89B |
| Dividends paid | -678.35M | -656.84M | -726.99M | -815.29M | -907.91M | -1.02B | -1.15B | -1.27B |
| Stock buybacks / issuance | -3.77B | -1.36B | -2.67B | -3.86B | -2.01B | -2.83B | -3.42B | -3.83B |
| Ending cash balance | 3.91B | 5.17B | 4.67B | 3.77B | 5.59B | 5.85B | 6.41B | 5.60B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.31B | 2.55B | 1.78B | 1.48B | 1.14B | 1.46B |
| Depreciation & amortization | 97.34M | 98.44M | 101.64M | 103.93M | 116.32M | 119.64M |
| Free cash flow | 1.02B | 2.38B | 1.59B | 1.22B | 809.82M | 1.27B |
| Dividends paid | -295.72M | -295.21M | -291.98M | -327.51M | -325.83M | -325.32M |
| Stock buybacks / issuance | -433.33M | -1.29B | -975.79M | -1.46B | -1.15B | -242.13M |
| Ending cash balance | 5.46B | 6.41B | 6.71B | 6.20B | 4.77B | 5.60B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 38.77 | 45.46 | 69.73 | 74.85 | 62.27 | 45.71 | 58.24 | 65.07 |
| ROA %i | 17.90 | 16.96 | 25.67 | 27.84 | 25.08 | 20.40 | 26.73 | 32.38 |
| ROIC %i | 24.25 | 23.08 | 37.04 | 42.65 | 37.16 | 28.19 | 38.11 | 47.34 |
| 5-year avg ROE %i | 25.64 | 32.25 | 43.00 | 52.78 | 58.22 | 59.60 | 62.16 | 61.23 |
| EBIT margin %i | 26.56 | 27.40 | 31.31 | 31.22 | 30.39 | 30.50 | 33.29 | 36.24 |
| FCF / sales %i | 29.76 | 19.15 | 22.15 | 14.82 | 26.84 | 28.55 | 29.37 | 21.05 |
| Current ratioi | 3.61 | 3.43 | 3.30 | 2.69 | 3.16 | 2.97 | 2.21 | 2.63 |
| Quick ratioi | 2.90 | 2.78 | 2.48 | 1.75 | 1.95 | 1.93 | 1.49 | 1.84 |
| Debt / assetsi | 37.41 | 39.91 | 31.43 | 29.11 | 26.68 | 26.59 | 21.01 | 15.87 |
| LT debt / equityi | 80.93 | 95.90 | 82.69 | 79.61 | 60.94 | 52.45 | 37.83 | 29.91 |
| Interest coveragei | 21.86 | 15.51 | 21.95 | 29.11 | 28.40 | 24.54 | 34.43 | 53.67 |
| Revenue CAGR (3Y) %i | 17.93 | 7.82 | 9.71 | 21.29 | 20.16 | 0.63 | 2.29 | 10.06 |
| Net income CAGR (3Y) %i | 33.84 | 9.87 | 17.97 | 28.09 | 26.06 | -0.69 | 5.18 | 17.22 |
| FCF CAGR (3Y) %i | 34.71 | 0.91 | 10.78 | -3.85 | 34.48 | 9.53 | 28.47 | 1.50 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 53.14 | 58.24 | 62.26 | 65.56 | 66.76 | 65.07 |
| ROA %i | 24.36 | 26.73 | 28.05 | 30.14 | 32.92 | 32.38 |
| ROIC %i | 34.11 | 38.11 | 40.98 | 43.41 | 47.07 | 47.34 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 32.19 | 33.29 | 34.19 | 34.93 | 35.29 | 36.24 |
| FCF / sales %i | 22.14 | 29.37 | 28.33 | 30.23 | 27.70 | 21.05 |
| Current ratioi | 2.45 | 2.21 | 2.21 | 2.26 | 2.54 | 2.63 |
| Quick ratioi | 1.58 | 1.49 | 1.54 | 1.56 | 1.69 | 1.84 |
| Debt / assetsi | 22.46 | 21.01 | 20.47 | 20.96 | 17.96 | 15.87 |
| LT debt / equityi | 39.22 | 37.83 | 36.59 | 36.76 | 35.24 | 29.91 |
| Interest coveragei | 30.33 | 34.43 | 38.12 | 41.93 | 46.25 | 53.67 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Manufacturing and servicing of wafer processing semiconductor manufacturing equipment100.00%
Region
China33.83%
Taiwan22.48%
Korea19.39%
Japan9.34%
United States6.58%
Southeast Asia5.36%
Europe3.01%
Quote time 2026-10-20 11:00:14 · For reference only, not investment advice and not tailored to your situation.
memory capex finally coming back online after the downturn and this name benefits as much as anyone from that. semi equipment cycle turns are brutal to time but feel like we’re past the bottom.